BioCardia(BCDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BCDA BioCardia

Market Closed 10-02 16:00:00 EDT

1.04

+0.02

+1.96%

盘后1.04

+0.000.00%

16:10 EDT

High1.05	Low1.03	Vol52.54K
Open1.04	D1 Closing1.02	Amplitude1.96%
Mkt Cap15.74M	Tradable Cap12.60M	Total Shares15.14M
T/O54.54K	T/O Rate0.43%	Tradable Shares12.12M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BCDA","market":"US","secType":"STK","nameCN":"BioCardia","latestPrice":1.04,"timestamp":1790971200000,"preClose":1.02,"halted":0,"volume":52537,"hourTrading":{"tag":"盘后","latestPrice":1.04,"preClose":1.04,"latestTime":"16:10 EDT","volume":7,"amount":7.28,"timestamp":1790971804464,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.01960784313725492,"floatShares":12117398,"shares":15138782,"eps":-0.73929,"marketStatus":"Market Closed","change":0.02,"latestTime":"10-02 16:00:00 EDT","open":1.04,"high":1.05,"low":1.03,"amount":54544,"amplitude":0.019608,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.73929,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.02,"preHourTrading":{"tag":"盘前","latestPrice":1.02,"preClose":1.02,"latestTime":"09:29 EDT","volume":1947,"amount":2032.679682,"timestamp":1790947741332,"change":0,"changeRate":0,"amplitude":0.098039},"postHourTrading":{"tag":"盘后","latestPrice":1.04,"preClose":1.04,"latestTime":"16:10 EDT","volume":7,"amount":7.28,"timestamp":1790971804464,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4131936965523121,"impliedVol":0.046,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BCDA","defaultTab":"news","newsList":[{"id":"2672577467","title":"BioCardia Files Revised FDA De Novo Pre-Submission for Helix Catheter Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2672577467","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672577467?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:15","pubTimestamp":1790860535,"startTime":"0","endTime":"0","summary":"BioCardia files revised FDA De Novo pre-submission for Helix catheter clearanceBioCardia filed a revised De Novo pre-submission with the FDA for marketing clearance of its Helix catheter for heart age","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL4LqHyY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4139","SG9999014039.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","BCDA","BK4112","IE00B3QW5Z07.USD","BCDF","IE00B64PRP62.GBP","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","NDAQ","IE00BN0W2T93.GBP","BK4588","BK4585","LU0314104364.USD","SG9999014013.SGD","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672792757","title":"BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter","url":"https://stock-news.laohu8.com/highlight/detail?id=2672792757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672792757?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:15","pubTimestamp":1790860500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA57W0PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672757790","title":"BioCardia - FDA Targets Initial Review Within 15 Days and Feedback or Meeting Within 70 Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2672757790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672757790?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:15","pubTimestamp":1790860500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA57W0PH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672718757","title":"BioCardia - FDA Raises no Concerns Regarding Helix Safety Data or Device Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2672718757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672718757?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:15","pubTimestamp":1790860500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA57W0PH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672510738","title":"BioCardia CEO Peter Altman Acquires $1,030 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672510738","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672510738?lang=en_us&edition=fundamental","pubTime":"2026-10-01 06:52","pubTimestamp":1790808753,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman acquires $1,030 in common sharesBioCardia President and CEO Peter Altman bought 1,000 common shares at USD 1.03.Directly held stake rose to 384,885 common shares.Disclaimer:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDLb9hpKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioCardia CEO Peter Altman Acquires $1,030 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669432122","title":"BioCardia CEO Peter Altman Acquires Common Shares Worth $1,995","url":"https://stock-news.laohu8.com/highlight/detail?id=2669432122","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669432122?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:15","pubTimestamp":1790208936,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman acquires common shares worth $1,995BioCardia President and CEO Peter Altman reported an open-market purchase of 1,900 common shares at USD 1.05.Directly held common stock po","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDLYWFLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioCardia CEO Peter Altman Acquires Common Shares Worth $1,995","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669860764","title":"BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and Pmda Cardiamp HF Shonin Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2669860764","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669860764?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:15","pubTimestamp":1790169300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUATCCQJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669848607","title":"BioCardia - to Submit Shonin Pre-Market Application to Pmda in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669848607","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669848607?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:15","pubTimestamp":1790169300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUATCCQJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669486073","title":"BioCardia - Market Clearance for Cardiamp in Japan Possible by Q4 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669486073?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:15","pubTimestamp":1790169300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUATCCQJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669486006","title":"BioCardia - to Submit De Novo Pre-Submission for Helix Cathter System to FDA This Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486006","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669486006?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:15","pubTimestamp":1790169300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUATCCQJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666937105","title":"BioCardia CEO Peter Altman Presents at H.C. Wainwright Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666937105","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666937105?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:31","pubTimestamp":1789043498,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman presents at H.C. Wainwright Global Investment ConferenceBioCardia to present at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-16, 2026, in New Yor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbGHcSK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","IE00BN0W2W23.USD","IE00BQXX3F31.USD","LU2095319765.USD","LU2210149790.SGD","IE00BQXX3C00.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4139","BCDF","BK4585","SG9999014005.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","NDAQ","BK4112","IE00BN0W2V16.EUR","BCDA","IE00BQXX3D17.EUR","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665357122","title":"BioCardia CEO Peter Altman Buys 800 Shares for $872","url":"https://stock-news.laohu8.com/highlight/detail?id=2665357122","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665357122?lang=en_us&edition=fundamental","pubTime":"2026-09-05 09:31","pubTimestamp":1788571871,"startTime":"0","endTime":"0","summary":"BioCardia CEO Peter Altman buys 800 shares for $872BioCardia President, CEO, director Peter Altman bought 800 common shares at USD 1.09 each.Altman’s direct holding rose to 381,985 BioCardia common sh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260905:nNDL2X5RnK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioCardia CEO Peter Altman Buys 800 Shares for $872","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706852","title":"BioCardia Price Target Maintained with a $25.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706852","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706852?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:02","pubTimestamp":1787587320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BCDA/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705192","title":"BioCardia: Advancing Regulatory Momentum in Helix Catheter and CardiAMP HF Programs Supports Buy Rating and Unchanged $25 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705192","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705192?lang=en_us&edition=fundamental","pubTime":"2026-08-24 23:55","pubTimestamp":1787586951,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on BioCardia today and set a price target of $25.00. Joseph Pantginis has given hi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/biocardia-advancing-regulatory-momentum-in-helix-catheter-and-cardiamp-hf-programs-supports-buy-rating-and-unchanged-25-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/biocardia-advancing-regulatory-momentum-in-helix-catheter-and-cardiamp-hf-programs-supports-buy-rating-and-unchanged-25-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCDA","HF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661775279","title":"BioCardia gets FDA confirmation of Helix meeting minutes","url":"https://stock-news.laohu8.com/highlight/detail?id=2661775279","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661775279?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:00","pubTimestamp":1787576434,"startTime":"0","endTime":"0","summary":"BioCardia (BCDA) announced receipt of FDA confirmation of the outcome of its pre-submission meeting on the Helix Transendocardial Delivery Catheter...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biocardia-gets-fda-confirmation-of-helix-meeting-minutes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biocardia-gets-fda-confirmation-of-helix-meeting-minutes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4139","BK4588","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279743","title":"BioCardia Advances Helix Catheter Toward De Novo Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279743","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279743?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:00","pubTimestamp":1787576416,"startTime":"0","endTime":"0","summary":"An update from BioCardia ( ($BCDA) ) is now available. On August 24, 2026, BioCardia announced that the U.S. Food and Drug Administration had confi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biocardia-advances-helix-catheter-toward-de-novo-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biocardia-advances-helix-catheter-toward-de-novo-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276715","title":"BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-on De Novo Pre-Submission for Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276715?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA4XLHLD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276711","title":"BioCardia - to Submit Follow-on Pre-Submission for Helix This Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276711?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA4XLHLD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BCDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290656","title":"BioCardia Receives Nasdaq Notice on Minimum Bid Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290656?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:59","pubTimestamp":1787345950,"startTime":"0","endTime":"0","summary":"BioCardia ( ($BCDA) ) has issued an update. On August 19, 2026, BioCardia disclosed that it had received a notice from Nasdaq after its common stoc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biocardia-receives-nasdaq-notice-on-minimum-bid-price?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biocardia-receives-nasdaq-notice-on-minimum-bid-price?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4139","BCDA","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661297731","title":"BioCardia Receives NASDAQ Notice for Trading Below $1 Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2661297731","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661297731?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:35","pubTimestamp":1787344524,"startTime":"0","endTime":"0","summary":"BioCardia receives Nasdaq notice for trading below $1 minimum bid price requirementBioCardia received a Nasdaq notice on Aug. 19, 2026 for failing the $1 minimum bid price rule for 30 consecutive sess","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLbZlJq2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biocardia.com","stockEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":-0.0631},{"period":"3month","weight":-0.1333},{"period":"6month","weight":-0.1333},{"period":"1year","weight":-0.2296},{"period":"ytd","weight":-0.168}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.066663},{"month":2,"riseRate":0.5,"avgChangeRate":-0.017269},{"month":3,"riseRate":0.25,"avgChangeRate":-0.022375},{"month":4,"riseRate":0.375,"avgChangeRate":0.007226},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.09523},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.005776},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.051846},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.048777},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.004864},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.04055},{"month":11,"riseRate":0.5,"avgChangeRate":0.042585},{"month":12,"riseRate":0.375,"avgChangeRate":-0.012187}],"exchange":"NASDAQ","name":"BioCardia","nameEN":"BioCardia"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioCardia(BCDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BioCardia(BCDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BioCardia,BCDA,BioCardia股票,BioCardia股票老虎,BioCardia股票老虎国际,BioCardia行情,BioCardia股票行情,BioCardia股价,BioCardia股市,BioCardia股票价格,BioCardia股票交易,BioCardia股票购买,BioCardia股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioCardia(BCDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BioCardia(BCDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction